Walmart is set to join the Nasdaq-100 Index, replacing British pharmaceutical giant AstraZeneca, as part of an index rebalancing effective before the market opens on January 20, according to a statement released by Nasdaq. This move follows Walmart’s earlier announcement in November that it would shift its primary stock listing from the New York Stock Exchange (NYSE) to Nasdaq, marking a significant change for the world’s largest retailer after decades on the NYSE.
The inclusion of Walmart in the Nasdaq-100 Index underscores the growing appeal of Nasdaq as a listing venue for large, high-profile companies. The Nasdaq-100 Index tracks 100 of the most valuable non-financial companies listed on the Nasdaq exchange and includes global leaders such as Apple, Nvidia, Microsoft, and Amazon. In addition to the main index, Walmart will also be added to the Nasdaq-100 Equal Weighted Index and the Nasdaq-100 Ex-Tech Sector Index, further expanding its presence across Nasdaq’s flagship benchmarks.
Companies often decide to change listing venues when they believe another exchange offers better alignment with their investor base, advanced trading technology, enhanced services, or lower listing and compliance costs. In recent years, Nasdaq has positioned itself as an attractive platform not only for technology companies but also for major consumer, healthcare, and industrial firms seeking broader exposure and index inclusion.
Several companies that moved from the NYSE to Nasdaq in 2025 cited the growing prestige and visibility of the Nasdaq-100 Index as a key factor in their decision. Being part of the index can lead to increased demand from index-tracking funds and institutional investors, potentially boosting liquidity and long-term shareholder value.
For Walmart, the transition represents more than a symbolic shift. It aligns the retail giant with a group of globally influential companies and reflects its evolving business model, which increasingly integrates e-commerce, technology, and data-driven operations. Meanwhile, AstraZeneca’s removal highlights the competitive and dynamic nature of major stock indices, where changes in market capitalization and listings can quickly reshape index composition.


SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
ADNOC Gas Targets Up to $4B Profit in 2026
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 



